The LDL/HDL ratio and atherosclerosis in ankylosing spondylitis

Z Rheumatol. 2017 Feb;76(1):58-63. doi: 10.1007/s00393-016-0092-4.

Abstract

Objectives: In ankylosing spondylitis (AS) patients, cardiac and vascular involvement may manifest as atherosclerosis and coronary artery disease. Systemic inflammation, oxidative stress, increased low-density lipoprotein (LDL) cholesterol and decreased high-density lipoprotein (HDL) cholesterol constitute a significant risk for atherosclerosis. This study investigated the relationship between carotid intima-media thickness (CIMT), LDL/HDL ratio, total oxidant status (TOS; an indicator of oxidative stress) and ischemic modified albumin (IMA; an ischemic marker in AS patients).

Patients and methods: Sixty AS patients were diagnosed using the Modified New York Criteria; 54 age- and gender-matched participants were included as controls. CIMT, LDL/HDL ratio, TOS and IMA were measured using the most appropriate methods.

Results: IMA was higher in AS patients compared to controls (p < 0.0001). TOS was also increased in AS patients (p = 0.005); as was CIMT (p < 0.0001). The LDL/HDL ratio was also greater in AS patients compared to controls (p = 0.047). A positive correlation was found between CIMT and LDL/HDL ratio among AS patients.

Conclusion: Elevated CIMT, IMA and TOS levels suggest an increased risk of atherosclerotic heart disease in AS patients. The LDL/HDL ratio was higher in AS patients compared to controls, and there was a correlation between LDL/HDL ratio and CIMT, albeit statistically weak. Therefore, the LDL/HDL ratio is not a reliable marker to predict atherosclerotic heart disease in AS patients.

Keywords: Ankylosing spondylitis; Atherosclerosis; Dyslipidemias; Ischemia-modified albumin; Oxidative Stress.

MeSH terms

  • Adult
  • Atherosclerosis / blood*
  • Atherosclerosis / diagnosis
  • Atherosclerosis / epidemiology*
  • Biomarkers / blood
  • Comorbidity
  • Female
  • Humans
  • Lipoproteins, HDL / blood*
  • Lipoproteins, LDL / blood*
  • Male
  • Prevalence
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Serum Albumin
  • Serum Albumin, Human
  • Spondylitis, Ankylosing / diagnosis
  • Spondylitis, Ankylosing / epidemiology*
  • Turkey / epidemiology

Substances

  • Biomarkers
  • Lipoproteins, HDL
  • Lipoproteins, LDL
  • Serum Albumin
  • ischemia-modified albumin
  • Serum Albumin, Human